US Stock MarketDetailed Quotes

VIRI Virios Therapeutics

Watchlist
  • 0.412
  • -0.010-2.30%
Close May 3 16:00 ET
  • 0.420
  • +0.009+2.07%
Post 18:21 ET
7.92MMarket Cap-1469P/E (TTM)

About Virios Therapeutics Company

Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.

Company Profile

SymbolVIRI
Company NameVirios Therapeutics
Listing DateDec 17, 2020
Issue Price10.00
Founded2012
CEOMr. Gregory Duncan
MarketNASDAQ
Employees4
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address44 Milton Avenue
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30009
Phone1-866-620-8655
Websitehttp://www.virios.com

Company Executives

  • Name
  • Position
  • Salary
  • Gregory Duncan
  • Chief Executive Officer and Chairman of the Board
  • 936.83K
  • Dr. Roger Michael Gendreau, M.D.,PhD
  • Chief Medical Officer
  • 566.18K
  • Angela Walsh
  • Senior Vice President, Finance, Principal Financial Officer, Principal Accounting Officer, Corporate Secretary and Treasurer
  • 426.82K
  • Ralph Grosswald
  • Senior Vice President, Operations
  • --
  • Richard Burch
  • Director
  • 51.49K
  • John C. Thomas,Jr
  • Independent Director
  • 66.49K
  • David Keefer
  • Independent Director
  • 72.99K
  • Dr. William L. Pridgen, M.D.
  • Independent Director
  • 51.49K
  • Dr. Abel De La Rosa,PhD
  • Independent Director
  • 63.99K
  • Dr. Richard J. Whitley,M.D.
  • Independent Director
  • 64.49K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg